ACS Infect Dis: Difference between revisions
From Bioblast
(Created page with "{{Journal |Title=[https://pubs.acs.org/journal/aidcbc ACS Infectious Disease] }}}") |
No edit summary |
||
| Line 1: | Line 1: | ||
{{Journal | {{Journal | ||
|Title=[https://pubs.acs.org/journal/aidcbc ACS Infectious | |Title=[https://pubs.acs.org/journal/aidcbc ACS Infectious Diseases] | ||
}}} | }} | ||
} | |||
Revision as of 09:21, 28 January 2019
| Journal title and website | ACS Infectious Diseases |
|---|
Publications
| Reference | Published | View | |
|---|---|---|---|
| Lu 2018 ACS Infect Dis | Lu X, Williams Z, Hards K, Tang J, Cheung CY, Aung HL, Wang B, Liu Z, Hu X, Lenaerts AJ, Woolhiser L, Hastings C, Zhang X, Wang Z, Rhee KY, Ding K, Zhang T, Cook GM (2018) A pyrazolo[1,5-a]pyridine inhibitor of the respiratory cytochrome bcc complex for the treatment of drug-resistant tuberculosis. ACS Infect Dis 5:239-49. | 2018 | PMID: 30485737 |
}
